Search research articles
Contact Us
Filters
Showing results (211-220 of 245) with videos related to
Page
of 25
Sort By:
Journal of Endocrinological Investigation
|
June 10, 2022
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data
A De Leo, G Vara, A Paccapelo, et al.
The Journal of Infectious Diseases
|
December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy
J L Lathey, C Tierney, S Y Chang, et al.
ESMO Open
|
October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
D Rossini, A Boccaccino, A Sbrana, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization
G Curigliano, L Marotti, C Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
The Journal of Molecular Diagnostics : JMD
|
February 20, 2009
A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens
Ayuko A Iverson, Cheryl Gillett, Paul Cane, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma
L Antonuzzo, M Maruzzo, U De Giorgi, et al.
Cancer Chemotherapy and Pharmacology
|
December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma
S Cereda, M Milella, S Cordio, et al.
British Journal of Cancer
|
July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F Loupakis, A Ruzzo, C Cremolini, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 245) with videos related to
Sort By:
Page
of 25
Journal of Endocrinological Investigation
|
June 10, 2022
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data
A De Leo, G Vara, A Paccapelo, et al.
The Journal of Infectious Diseases
|
December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy
J L Lathey, C Tierney, S Y Chang, et al.
ESMO Open
|
October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
D Rossini, A Boccaccino, A Sbrana, et al.
Breast (Edinburgh, Scotland)
|
January 7, 2026
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization
G Curigliano, L Marotti, C Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
The Journal of Molecular Diagnostics : JMD
|
February 20, 2009
A single-tube quantitative assay for mRNA levels of hormonal and growth factor receptors in breast cancer specimens
Ayuko A Iverson, Cheryl Gillett, Paul Cane, et al.
The Pharmacogenomics Journal
|
December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
F Graziano, A Ruzzo, E Canestrari, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma
L Antonuzzo, M Maruzzo, U De Giorgi, et al.
Cancer Chemotherapy and Pharmacology
|
December 15, 2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma
S Cereda, M Milella, S Cordio, et al.
British Journal of Cancer
|
July 16, 2009
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
F Loupakis, A Ruzzo, C Cremolini, et al.
Page
of 25